Rossari Biotech Capacity Expansion

Rossari Biotech Earnings Call Transcript: Key Takeaways

Rossari Biotech achieved record quarterly revenue and EBITDA despite volatile raw material costs and logistical headwinds.

Call

Guides 15% growth

Rossari Biotech Results Update

Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.

Rossari Biotech Investor Presentation: Key Takeaways

Rossari Biotech reported record quarterly revenue of Rs. 697.6 Cr (up 19% YoY) and EBITDA of Rs. 87 Cr (up 21% YoY). Performance driven by volume and product mix.

Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY

Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.

Key figure

Net profit ₹38.9 Cr · +5.4% YoY

Rossari Biotech Other Announcement

Rossari Biotech submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes minor reporting adjustments for two promoter group members.

Rossari Biotech Board Meeting Date

Rossari Biotech will hold a board meeting on October 17, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.

Step Two Corporation Capacity Expansion: ₹10 Cr Investment

Step Two Corporation's board approved entry into retail financing of e-scooters, e-rickshaws and batteries, with an estimated investment of Rs.10 Crore. The move targets the growing e-vehicle and battery replacement market.

Value

₹10.00 Cr

Step Two Corporation Capacity Expansion

Step Two Corporation will enter electric two-wheeler and battery lending, launching first in three locations. A new corporate logo was also adopted, a visual change only.

initial launch locations

3.0 locations

Global Health Capacity Expansion: ₹997 Cr Investment

Medanta plans a 500-bed Ghaziabad hospital over 3-4 years. Project cost is Rs 997 Crore, funded by internal accruals and debt.

Value

₹997.0 Cr

Execution

3-4 years, phased

hospital beds

500.0 beds

Gujarat Inject (Kerala) Capacity Expansion

Gujarat Inject Kerala Ltd leased two Ahmedabad industrial premises for factory and R&D use. The five-year deals include 5% escalation and a two-year lock-in.

Execution

5 years (2-year lessee lock-in)

Aelea Commodities Capacity Expansion: ₹114 Cr Investment

Aelea's board approved ₹114 crore to add 90 MT manufacturing capacity and build a staff housing colony in Surat. Completion expected within 30 months from February 2027.

Value

₹114.0 Cr

Execution

30 months from February 2027

manufacturing capacity addition

90.0 MT

Kaynes Technology India Capacity Expansion

Kaynes Technology has incorporated a wholly owned subsidiary, Kaynes Arabia Electronics Company, in Saudi Arabia to manufacture electronic products for GCC markets. The company holds 100% ownership and the authorised share capital is SAR 100,000.